Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucius Doh

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
The New England Journal of Medicine|March 10, 2006
Renal-cell carcinomaLucius Doh, Amarinthia E Curtis, Bin S Teh
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|September 8, 2016
Image-guided hypofractionated proton beam therapy for low-risk prostate cancer: Analysis of quality of life and toxicity, PCG GU 002Carlos Enrique Vargas, William Fred Hartsell, Megan Dunn, et al.
American Journal of Clinical Oncology|November 3, 2015
Hypofractionated Versus Standard Fractionated Proton-beam Therapy for Low-risk Prostate Cancer: Interim Results of a Randomized Trial PCG GU 002Carlos E Vargas, William F Hartsell, Megan Dunn, et al.
Advances in Radiation Oncology|September 12, 2018
Initial toxicity, quality-of-life outcomes, and dosimetric impact in a randomized phase 3 trial of hypofractionated versus standard fractionated proton therapy for low-risk prostate cancerCarlos E Vargas, Matthew Q Schmidt, Joshua R Niska, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
The New England Journal of Medicine|March 10, 2006
Renal-cell carcinomaLucius Doh, Amarinthia E Curtis, Bin S Teh
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|September 8, 2016
Image-guided hypofractionated proton beam therapy for low-risk prostate cancer: Analysis of quality of life and toxicity, PCG GU 002Carlos Enrique Vargas, William Fred Hartsell, Megan Dunn, et al.
American Journal of Clinical Oncology|November 3, 2015
Hypofractionated Versus Standard Fractionated Proton-beam Therapy for Low-risk Prostate Cancer: Interim Results of a Randomized Trial PCG GU 002Carlos E Vargas, William F Hartsell, Megan Dunn, et al.
Advances in Radiation Oncology|September 12, 2018
Initial toxicity, quality-of-life outcomes, and dosimetric impact in a randomized phase 3 trial of hypofractionated versus standard fractionated proton therapy for low-risk prostate cancerCarlos E Vargas, Matthew Q Schmidt, Joshua R Niska, et al.
Pageof 1